3,090 results found for ""

Alina Bengert-Lombardi standing outdoors, holding a bouquet of flowers

Blog Post

Volunteer Viewpoints: Alina Bengert-Lombardi

Alina Bengert-Lombardi has volunteered at the Regeneron International Science and Engineering Fair for the past ten years. We sat down with Alina, who shared some of her experiences and favorite memories from over the years.

Shriya Tailor holding her invention's prototype.

Blog Post

Renewable energy from space? One student hopes to harness it.

Middle School student, Shriya Tailor, received the Lemelson Early Inventor prize for developing a prototype for her “Solar Energy Station” invention.

Congratulations to the 2022 STS Finalists!

Blog Post

Forty accomplished young scientists named Finalists in the 2022 Regeneron Science Talent Search

The 40 finalists in the Regeneron Science Talent Search 2022 have been named.

 

2022 Finalists

Society for Science  and Regeneron Pharmaceuticals, Inc. congratulate the 40 finalists in the Regeneron Science Talent Search 2021, the nation’s oldest and most prestigious science and math competition for high school seniors.

Regeneron STS 2022: 300 sparkling scholars in STEM.

Blog Post

The Regeneron STS 2022 Top 300 Scholars are sparkling in STEM fields

The Regeneron Science Talent Search 2022 top 300 scholars, not only sparkle in the field of STEM, but can also speak multiple languages, produce music and create community.

George Yancopoulos, Regeneron Scientific Founder, President and Chief Scientific Officer

Blog Post

Conversations with Maya: George Yancopoulos

Middle school student, Anna Kilponen, received the Lemelson Early Inventor Prize.

Blog Post

One student aims to keep swimmers safe during the coronavirus pandemic

Middle school student, Anna Kilponen, received the Lemelson Early Inventor Prize for creating a water resistant face mask.

Blog Post

Spotlight Series: National Leadership Council member, Kevin Heller

About Kevin: Kevin is Executive Vice President, Research and Development for Jasper Therapeutics, a biotechnology company developing and commercializing safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. He is also an adjunct professor of medicine at Yale School of Medicine. In previous roles, Kevin served as Chief Medical Officer at NextCure and Vice President and head of antibody clinical development at Incyte. He joined Incyte from AstraZeneca, where he was Senior Medical Director, overseeing global medicines development in oncology. Kevin began his biopharma industry experience at Bristol Myers Squibb, where he led early development programs and was responsible for authoring and managing first-in-human clinical trials.

Congratulations to the 2022 Regeneron Science Talent Search scholars.

Blog Post

Top 300 Scholars named in Regeneron Science Talent Search 2022

The Society for Science announced the top 300 scholars in the Regeneron Science Talent Search 2022.